Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Woo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Research|October 23, 1997
Nucleocytoplasmic functionality of metallothioneinE S Woo, J S Lazo
Oncogene|May 29, 1999
Cell cycle dependent subcellular distribution of Cdc25B subtypesE S Woo, R L Rice, J S Lazo
Current Opinion in Biotechnology|February 13, 2001
Real-time molecular and cellular analysis: the new frontier of drug discoveryD L Taylor, E S Woo, K A Giuliano
Journal of Cellular Physiology|November 24, 1999
Energy-dependent nuclear binding dictates metallothionein localizationE S Woo, D Dellapiazza, A S Wang, et al.
Molecular Carcinogenesis|March 1, 1994
DNA polymerase arrest by adducted trivalent chromiumL C Bridgewater, F C Manning, E S Woo, et al.
Chemico-Biological Interactions|July 29, 1998
The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugsJ S Lazo, S M Kuo, E S Woo, et al.
Experimental Cell Research|May 1, 1996
Nucleophilic distribution of metallothionein in human tumor cellsE S Woo, Y Kondo, S C Watkins, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panelE S Woo, A Monks, S C Watkins, et al.
Cancer Research|May 15, 1995
Metallothionein null cells have increased sensitivity to anticancer drugsY Kondo, E S Woo, A E Michalska, et al.
Molecular Pharmacology|March 1, 1994
Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cellsY Y Yang, E S Woo, C E Reese, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Research|October 23, 1997
Nucleocytoplasmic functionality of metallothioneinE S Woo, J S Lazo
Oncogene|May 29, 1999
Cell cycle dependent subcellular distribution of Cdc25B subtypesE S Woo, R L Rice, J S Lazo
Current Opinion in Biotechnology|February 13, 2001
Real-time molecular and cellular analysis: the new frontier of drug discoveryD L Taylor, E S Woo, K A Giuliano
Journal of Cellular Physiology|November 24, 1999
Energy-dependent nuclear binding dictates metallothionein localizationE S Woo, D Dellapiazza, A S Wang, et al.
Molecular Carcinogenesis|March 1, 1994
DNA polymerase arrest by adducted trivalent chromiumL C Bridgewater, F C Manning, E S Woo, et al.
Chemico-Biological Interactions|July 29, 1998
The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugsJ S Lazo, S M Kuo, E S Woo, et al.
Experimental Cell Research|May 1, 1996
Nucleophilic distribution of metallothionein in human tumor cellsE S Woo, Y Kondo, S C Watkins, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panelE S Woo, A Monks, S C Watkins, et al.
Cancer Research|May 15, 1995
Metallothionein null cells have increased sensitivity to anticancer drugsY Kondo, E S Woo, A E Michalska, et al.
Molecular Pharmacology|March 1, 1994
Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cellsY Y Yang, E S Woo, C E Reese, et al.
Pageof 2